Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Other Non Operating Income (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Other Non Operating Income for 4 consecutive years, with $513.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Non Operating Income fell 94.7% to $513.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $34697.0, a 168.7% increase, with the full-year FY2024 number at $10323.0, up 210.47% from a year prior.
  • Other Non Operating Income was $513.0 for Q3 2025 at bioAffinity Technologies, down from $38053.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $212258.0 in Q2 2022 to a low of -$212000.0 in Q3 2022.
  • A 4-year average of $4770.4 and a median of $513.0 in 2025 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: tumbled 202.19% in 2024, then skyrocketed 3805200.0% in 2025.
  • bioAffinity Technologies' Other Non Operating Income stood at -$212000.0 in 2022, then surged by 99.4% to -$1281.0 in 2023, then crashed by 202.19% to -$3871.0 in 2024, then soared by 113.25% to $513.0 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Other Non Operating Income are $513.0 (Q3 2025), $38053.0 (Q2 2025), and $2.0 (Q1 2025).